Cyclerion Therapeutics (CYCN) Accumulated Expenses (2018 - 2025)

Cyclerion Therapeutics' Accumulated Expenses history runs 8 years deep, the most recent figure standing at $198000.0 for Q4 2025.

• In Q4 2025, Accumulated Expenses fell 30.04% year-over-year to $198000.0; the TTM figure through Dec 2025 stood at $198000.0 (down 30.04% YoY), while the FY2025 annual figure was $198000.0, down 30.04% from the prior year.
• Accumulated Expenses for Q4 2025 stood at $198000.0, down from $351000.0 in the prior quarter.
• The five-year high for Accumulated Expenses was $4.8 million in Q2 2022, with the low at $18000.0 in Q3 2024.
• The 5-year median for Accumulated Expenses is $325500.0 (2023), against an average of $964000.0.
• The sharpest annual moves came in 2023 and 2025: Accumulated Expenses tumbled 95.59% in 2023, then surged 1850.0% in 2025.
• Cyclerion Therapeutics' Accumulated Expenses stood at $2.9 million in 2021, then slumped by 91.8% to $238000.0 in 2022, then tumbled by 62.18% to $90000.0 in 2023, then soared by 214.44% to $283000.0 in 2024, then sank by 30.04% to $198000.0 in 2025.
• Business Quant data shows CYCN's Accumulated Expenses at $198000.0 in Q4 2025, $351000.0 in Q3 2025, and $266000.0 in Q2 2025.